Why do antioxidants fail to provide clinical benefit? |
| |
Authors: | Ascan Warnholtz and Thomas Münzel |
| |
Institution: | (1) Division of Cardiology, University Hospital Eppendorf, Hamburg, Germany |
| |
Abstract: | The results of recent randomized trials to test the influence of antioxidants on coronary-event rates and prognosis in patients
with coronary-artery disease were disappointing. In none of these studies did the use of vitamin E improve prognosis. In contrast,
treatment of coronary-artery disease with angiotensin-converting-enzyme (ACE) inhibitors reduced coronary-event rates and
improved prognosis. ACE inhibition prevents the formation of angiotensin II, which has been shown to be a potent stimulus
of superoxide-producing enzymes in atherosclerosis. The findings suggest that inhibition of superoxide production at enzymatic
levels, rather than symptomatic superoxide scavenging, may be the better choice of treatment. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|